Found 169 matching trials
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies how well imatinib mesylate works in...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma PHASE2 RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Show More Location
Multiple Locations
Learn More & Join Trial
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim N/A RATIONALE: Studying samples of blood from patients treated with sargramosti...
Show More Location
Multiple Locations
Learn More & Join Trial
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas PHASE1 This phase I/II trial studies the side effects and best dose of temozolomid...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Biomarkers of Synaptic Damage in Multiple Sclerosis N/A A prospective and retrospective cohort study of about five years will be pe...
Show More Learn More & Join Trial
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Multiple Locations
Learn More & Join Trial
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma PHASE2 This phase II trial studies how well dinutuximab works when given with sarg...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer NA RATIONALE: AZD2171 may stop the growth of tumor cells by blocking some of t...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer PHASE1 Phase I trial to compare the effectiveness of vaccine therapy with or witho...
Show More Location
Lombardi Comprehensive Cancer Center at Georgetown University
Learn More & Join Trial
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis PHASE1 Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial